Eberhardt Christiane S, Siegrist Claire-Anne
Centre de vaccinologie, HUG, 1211 Genève 14.
Centre de vaccinologie et d'immunologie néonatale, Département de pathologie et immunologie et Département de pédiatrie générale, Faculté de médecine, Université de Genève, 1211 Genève 4.
Rev Med Suisse. 2021 Feb 17;17(726):353-357.
Considerable efforts have been undertaken to quickly develop COVID-19 vaccines that protect vulnerable adults against severe disease and thus limit the socio-economic and public health impact of the current pandemic. To justify COVID-19 vaccination for the pediatric population, which rarely suffers from severe COVID-19, vaccines will need to have fully demonstrated safety and efficacy in preventing complications and viral transmission. This article summarizes the different vaccine platforms that are currently being tested and discusses practical and ethical aspects of childhood COVID-19 vaccination. It also examines the already deleterious effects of the pandemic on routine childhood vaccine coverage and insists on the imperative to vaccinate all children timely as recommended by national immunization programs.
人们已经付出了巨大努力，迅速研发出针对新冠病毒病（COVID-19）的疫苗，以保护易感染的成年人免受重症困扰，从而减轻当前大流行对社会经济和公共卫生的影响。对于很少患重症COVID-19的儿童群体，要证明接种COVID-19疫苗的合理性，疫苗需要在预防并发症和病毒传播方面充分证明其安全性和有效性。本文总结了目前正在测试的不同疫苗平台，并讨论了儿童COVID-19疫苗接种的实际和伦理方面。文章还审视了大流行对常规儿童疫苗接种覆盖率已经产生的有害影响，并强调必须按照国家免疫规划的建议及时为所有儿童接种疫苗。
